Busulfan and fludarabine is a safe and effective conditioning regimen for allogenic sibling bone marrow transplantation in adults with acute myeloid leukemia

被引：0
|
作者：
Fagot, T. [1 ]
Konopacki, J. [1 ]
Malfuson, J. [1 ]
Janus, G. [1 ]
Souleau, B. [1 ]
De Revel, T. [1 ]
机构：
[1] Hop Percy, Clamart, France
来源：
EXPERIMENTAL HEMATOLOGY | 2007年 / 35卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：72 / 73
页数：2
相关论文
共 50 条
  • [21] Thiotepa-Busulfan-Fludarabine in Comparison to Busulfan-Cyclophosphamide As Myeloablative Conditioning Regimen Pre Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
    Saraceni, Francesco
    Beohou, Eric
    Labopin, Myriam
    Arcese, William
    Bonifazi, Francesca
    Stepensky, Polina
    Aljurf, Mahmoud
    Bruno, Benedetto
    Pioltelli, Pietro
    Passweg, Jakob R.
    Socie, Gerard
    Santarone, Stella
    Yakoub-Agha, Ibrahim
    Savani, Bipin N.
    Mohty, Mohamad
    Nagler, Arnon
    BLOOD, 2017, 130
  • [22] Transplantation of allogenic bone marrow in patients with chronic myeloid leukemia
    Lyubimova, L. S.
    Savchenko, V. G.
    Demidova, I. A.
    Zhelnova, E. I.
    Domracheva, E. V.
    Misyurin, A. V.
    Parovichnikova, E. N.
    Galtseva, I. V.
    Klyasova, G. A.
    Poreshina, L. P.
    Kutyina, R. M.
    Shpakova, A. P.
    Glasko, E. N.
    Kuzmina, L. A.
    Kaplanskaya, I. B.
    Gribanova, E. O.
    Pokrovskaya, O. S.
    Gaponova, T. V.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2007, 52 (06): : 27 - 31
  • [23] Outcomes of Elderly Patients Undergoing Allogeneic Transplantation for Acute Myeloid Leukemia with Fludarabine/Melphalan or Fludarabine/TBI Conditioning Regimen
    Woods, Ashley C.
    Joseph, Nisha
    Rupji, Manali
    Liu, Yuan
    Langston, Amelia
    Waller, Edmund K.
    BLOOD, 2019, 134
  • [24] Reduced-Intensity Conditioning With Fludarabine and Busulfan Versus Fludarabine and Melphalan for Patients With Acute Myeloid Leukemia: A Report From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
    Baron, Frederic
    Labopin, Myriam
    Peniket, Andy
    Jindra, Pavel
    Afanasyev, Boris
    Sanz, Miguel A.
    Deconinck, Eric
    Nagler, Arnon
    Mohty, Mohamad
    CANCER, 2015, 121 (07) : 1048 - 1055
  • [25] Hematopoetic Stem Cell Transplant Using Fludarabine- Busulfan Based Conditioning Regimen in Pediatric Acute Myeloid Leukemia
    Bhat, S.
    Chakraborty, S.
    Venkatagiri, A.
    Joshi, R.
    Badiger, S.
    Kailasnath, V.
    Srinivasarao, N. K.
    Damodar, S.
    Mallya, P.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S217 - S218
  • [26] Thiotepa, busulfan and fludarabine: A conditioning-regimen for adult patients with acute lymphoblastic leukemia
    Banet, A.
    Bazarbachi, A.
    Labopin, M.
    Dulery, R.
    Malard, F.
    Van de Wyngaert, Z.
    Bonnin, A.
    Radici, V.
    Belhocine, R.
    Sestili, S.
    El-Cheikh, J.
    Mohty, M.
    Brissot, E.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 110 - 110
  • [27] Myeloablative Dose of Busulfan and Fludarabine Combined with In Vivo T Cell Depletion Is Safe and Effective Conditioning for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients
    Avenoso, Daniele
    Mehra, Varun
    Slonim, Liron Barnea
    de Farias, Madson
    Alshehri, Hassan
    Bouziana, Styliani
    Krishnamurthy, Pramila
    Kulasekararaj, Austin
    Dazzi, Francesco
    Wood, Henry
    Kenyon, Michelle
    Leung, Ye Ting
    Anteh, Sandra
    Shah, Mili Naresh
    Hannah, Guy
    Serpenti, Fabio
    Gameil, Amna
    Bourlon, Christianne
    Dragoi, Oana Diana
    Pagliuca, Antonio
    Potter, Victoria
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (11): : 698.e1 - 698.e6
  • [28] Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
    Francesco Saraceni
    Myriam Labopin
    Arne Brecht
    Nicolaus Kröger
    Matthias Eder
    Johanna Tischer
    Hélène Labussière-Wallet
    Hermann Einsele
    Dietrich Beelen
    Donald Bunjes
    Dietger Niederwieser
    Tilmann Bochtler
    Bipin N. Savani
    Mohamad Mohty
    Arnon Nagler
    Journal of Hematology & Oncology, 12
  • [29] Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
    Saraceni, Francesco
    Labopin, Myriam
    Brecht, Arne
    Kroeger, Nicolaus
    Eder, Matthias
    Tischer, Johanna
    Labussiere-Wallet, Helene
    Einsele, Hermann
    Beelen, Dietrich
    Bunjes, Donald
    Niederwieser, Dietger
    Bochtler, Tilmann
    Savani, Bipin N.
    Mohty, Mohamad
    Nagler, Arnon
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
  • [30] Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission
    Saraceni, Francesco
    Labopin, Myriam
    Hamladji, Rose-Marie
    Mufti, Ghulam
    Socie, Gerard
    Shimoni, Avichai
    Delage, Jeremy
    Deconinck, Eric
    Chevallier, Patrice
    Blaise, Didier
    Sanz, Jaime
    Huynh, Anne
    Forcade, Edouard
    Savani, Bipin N.
    Mohty, Mohamad
    Nagler, Arnon
    ONCOTARGET, 2018, 9 (03) : 3379 - 3393
12345